MedTrace Logo

Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS)

NCT02572479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-03-07

No results posted yet for this study

Summary

The proposed observational trial will collect substantial data concerning dietary intake documented by ALS patients complemented by the analysis of fatty acid distribution in erythrocyte lipids. Both data sets are related to disease status and progress.

Conditions

Sponsors & Collaborators

  • Jena University Hospital

    collaborator OTHER

  • University of Jena

    lead OTHER

Principal Investigators

  • Julian Grosskreutz, PhD · Jena University Hospital, Hans Berger Department of Neurology

  • Christine Dawczynski, PhD · University of Jena, Department of Nutritional Biochemistry and Physiology

  • Stefan Lorkowski, Professor · University of Jena, Department of Nutritional Biochemistry and Physiology

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02572479 on ClinicalTrials.gov